AstraZeneca has agreed a deal worth up to $ ... The partnership also comes amid a flurry of other news about the application of GenAI techniques to the discovery and development of large-molecule ...

The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and ... that has attracted alliances with AstraZeneca, MSD, and Almirall. AMD has been considerably ...

The U.K. government is defending its negotiations with AstraZeneca (AZN), after the pharmaceutical company dropped a planned $558M investment ...

A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in northwest England.

AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in ...

Absci Stock Down 2.9 % Shares of ABSI opened at $3.71 on Friday. The company has a quick ratio of 5.63, a current ratio of 5.63 and a debt-to-equity ratio of 0.01. Absci has a 52-week low of $2.45 ...

An AstraZeneca spokesperson told Sky News: "Following discussions with the current government, we are no longer pursuing our planned investment at Speke. "Several factors have influenced this ...

In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow to the government's recent zeal for growth. Instead of injecting £450m ...

Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...

Britain on Monday hit back at AstraZeneca over the collapse of a 450 million pound ($558.5 million) investment, saying the drugmaker had scaled back the research and development portion of its plans, ...